Skanderbeg Capital Advisors is a boutique merchant bank and advisory group focused on identifying undervalued companies with highly prospective business opportunities. We primarily focus on public companies in the natural resource, cannabis, technology, biotech and special situations sectors
Skanderbeg Capital Advisors has multiple areas of expertise and focus: Structuring, investing, financing and advising on capital markets strategies that are synergistic with co investment partners and financiers.
Structuring companies is one of the main pillars of our business. Our strategy is to focus on identifying sectors and cycles that are rapidly emerging and compelling with significant growth ahead. We are connected with the top bankers, investors and financiers in the venture market. As such, we see consistent high quality assets and deal flow, and are able to quickly capitalize on a compelling opportunity.
We have often found that there are many great companies that are undervalued because the management teams are great fundamental operators, but lack the capital markets expertise to expose and unlock shareholder value through exposure via marketing, strategic funding and investor relations. Operating from a “shareholder first” mentality, we seek to align ourselves with management and shareholder’s interests by only working with companies that we own equity in. Via a private placement or open market buying, once a shareholder, we look to implement the full strength of our networks and proven advisory services to function as a Capital Markets Partner.
Skanderbeg Capital Advisors has led, been a syndicate member and/or advised on $100M in funding since January of 2016. Some highlights…
$46 Million – K92 Mining
$11 Million – Kenadyr Mining
$9.2 Million – Golden Arrow Resources
$10 Million – Lithium X Energy
$7.4 Million – First Cobalt Corp
$6.5 Million – Rise Gold Corp